Seeking Alpha

Jazz Pharmaceuticals (JAZZ) announces plans for underwritten public offering of 5.375M shares of...

Jazz Pharmaceuticals (JAZZ) announces plans for underwritten public offering of 5.375M shares of its stock held by certain shareholders. JAZZ will not receive any proceeds from the offering. Barclays is acting as sole book-running manager for the offering. Shares -2.1% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)